Novavax Inc. stock underperforms Wednesday when compared to competitors | news.google.com • |
Novavax Inc. stock underperforms Wednesday when compared to competitors | news.google.com • |
Novavax Inc. stock underperforms Wednesday when compared to competitors | news.google.com • |
Novavax, Inc. (NASDAQ:NVAX) is Shah Capital Management's 2nd Largest Position | news.google.com • |
Novavax Inc. stock underperforms Tuesday when compared to competitors | news.google.com • |
Novavax Inc. stock underperforms Tuesday when compared to competitors | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-08-08 | 2024-06 | 1.82 | 0.99 | -0.83 | -45.60% |
2024-05-10 | 2024-03 | -1.04 | -1.05 | -0.01 | -0.96% |
2024-02-28 | 2023-12 | -0.49 | -1.44 | -0.95 | -193.88% |
2023-11-09 | 2023-09 | -1.82 | -1.26 | 0.56 | 30.77% |
2023-08-08 | 2023-06 | -1.24 | 0.58 | 1.82 | 146.77% |
2023-05-09 | 2023-03 | -3.38 | -3.41 | -0.03 | -0.89% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-09 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-08-08 | B. Riley Securities | Upgrade | Neutral | Buy |
2023-05-09 | HC Wainwright & Co. | Upgrade | Buy | |
2023-02-28 | B. Riley Securities | Downgrade | Buy | Neutral |
2023-02-12 | HC Wainwright & Co. | Upgrade | Buy | |
2023-01-01 | HC Wainwright & Co. | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-06-11 | ALTON GREGG H | Director | 10.47K | Conversion of Exercise of derivative security |
2024-06-11 | DOUGLAS RICHARD H | Director | 43.92K | Conversion of Exercise of derivative security |
2024-06-16 | DUBOVSKY FILIP | Officer | 66.61K | Sale |
2024-08-15 | KELLY JAMES PATRICK | Chief Financial Officer | 14.43K | Conversion of Exercise of derivative security |
2024-06-11 | KING RACHEL K | Director | 18.92K | Conversion of Exercise of derivative security |
2024-06-11 | MCGLYNN MARGARET G | Director | 10.47K | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | State Street Corporation | 11.68M | 86.78M | 12.37% |
2023-06-29 | Vanguard Group Inc | 10.57M | 78.55M | 11.20% |
2023-06-29 | Blackrock Inc. | 6.99M | 51.97M | 7.41% |
2023-09-29 | Shah Capital Management | 6.33M | 45.83M | 6.71% |
2023-06-29 | Bank of America Corporation | 2.18M | 16.23M | 2.31% |
2023-06-29 | Morgan Stanley | 2.08M | 15.46M | 2.20% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-08-30 | SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 9.38M | 75.07M | 9.94% |
2023-06-29 | Vanguard Total Stock Market Index Fund | 2.64M | 19.60M | 2.79% |
2023-06-29 | Vanguard Small-Cap Index Fund | 2.23M | 16.56M | 2.36% |
2023-08-30 | iShares Russell 2000 ETF | 2.01M | 16.10M | 2.13% |
2023-06-29 | Vanguard Small-Cap Growth Index Fund | 1.28M | 9.48M | 1.35% |
2023-06-29 | Vanguard Extended Market Index Fund | 1.21M | 8.98M | 1.28% |
Split | Date |
---|---|
1 : 20 | 2019-05-10 |
-
Back to 195 by Tuesday
-
Lets close at 230 today!!
-
Expect Monday this will be very expensive
-
-
When AZN reached 6 cases of blood clog back then, they thought it didn’t matter because it was only six. As more people receive JNJ, more blood blog cases will continue until enough cases to call Biden or Fauci’ turn back to JNJ. These two old manipulative political foxes.
-
The CEO stepped down for personal reason ? Many manager positions in NVAX accounting / finance department still open. CFO doesn’t have enough supports and can’t manage it on him own. Personal reason =
Mentally overwhelmed by doing footwork ?? https://novavax.applicantpro.com/jobsearch/?classification=fte_and_temps -
https://finance.yahoo.com/news/uk-trial-switching-covid-19-230100707.html
LONDON, April 14 (Reuters) - A UK study into using different COVID-19 vaccines in two-dose inoculations is being expanded to include shots made by Moderna and Novavax, researchers said on Wednesday.
-
Novavax to Participate in Fireside Chat at Goldman Sachs Virtual Conference
Fireside chat details:
Date: Tuesday, April 13, 2021
Time: 2:30 – 3:20 p.m. Eastern Time (ET)
Panel title: COVID-19 Vaccines – Staying Ahead of the Curve
Novavax participant: Vivek Shinde, M.D., M.P.H., Vice President, Clinical DevelopmentThis event is open to Goldman Sachs
-
https://www.google.com/amp/s/news.yahoo.com/amphtml/south-korea-says-five-companies-081205579.html
South Korea to begin producing Novavax COVID-19 vaccine as early as June
-
-
Should we be Selling tho?
-
In my opinion All cryptos will hit 50% + EOY. (Invest with your own risk/reward and DD).Get 10% bonus at following link in Binance . Their savings rate for USDT , BNB in more that 6.30%, bank rate is 0.05% !!!!!! Hahaha
https://accounts.binance.com/en/register?ref=NPF0TKH6 -
-
Is it too late to load here?
-
No idea why people are posting news about Dyadic, a $125m Cap stock with news about entering phase 1 for variants..so what? What are the odds this company makes any progress? Imagine the timeline they would need..they are way too late to the game and underfunded..
-
-
Can you imagine the impact on future industry efforts on emergency biomeds if governments were to agree on stripping IP profits away from a vaccine for a relatively low death rate virus like Covid? Companies would simply not focus efforts on vaccines and everyone would suffer in a future worse case...that is not how capitalism works (and rightfully so) folks...don’t need to be a republican to be clearly aware of that..don’t be a sucka, instead, use this after hours manipulation on low volume trading to buy at a local dip within extended hours using limit purchase orders!
$NVAX -
Can you imagine the impact on future industry efforts on emergency biomeds if governments were to agree on stripping IP profits away from a vaccine for a relatively low death rate virus like Covid? Companies would simply not focus efforts on vaccines and everyone would suffer in a future worse case...that is not how capitalism works (and rightfully so) folks...don’t need to be a republican to be clearly aware of that..don’t be a sucka, instead, use this after hours manipulation on low volume trading to buy at a local dip within extended hours using limit purchase orders!
-
$NVAX if some stupid article about non-action coming out of a meeting is all it takes to manipulate low volume selling in the after hours, my suggestion is to buy in the pre-hours before the next opening to buy at a silly dip. Manipulation noise is stupid until you recognize the opportunity to buy at a quick low volume dip
-
-
Novavax Inc. stock underperforms Wednesday when compared to competitors
news.google.com • -
Novavax Inc. stock underperforms Wednesday when compared to competitors
news.google.com • -
Novavax Inc. stock underperforms Wednesday when compared to competitors
news.google.com • -
Novavax Inc. stock underperforms Tuesday when compared to competitors
news.google.com • -
Novavax Inc. stock underperforms Tuesday when compared to competitors
news.google.com • -
Novavax Inc. stock underperforms Tuesday when compared to competitors
news.google.com • -
Why Novavax is Gaining Ground in COVID-19 Vaccine Race
news.google.com • -
Novavax Inc. stock underperforms Monday when compared to competitors
news.google.com • -
Novavax Inc. stock underperforms Monday when compared to competitors
news.google.com • -
(NVAX) Trading Report
news.google.com • -
Novavax Inc. stock outperforms competitors on strong trading day
news.google.com • -
Should You Buy Novavax Stock After This Regulatory Win?
news.google.com • -
Should You Buy Novavax Stock After This Regulatory Win?
news.google.com • -
Novavax Inc. stock underperforms Thursday when compared to competitors
news.google.com • -
Novavax Inc. stock underperforms Thursday when compared to competitors
news.google.com • -
Why Are Novavax Shares Trading Lower Today?
news.google.com • -
Novavax, Inc. (NVAX) Baird 2024 Global Healthcare Conference (Transcript)
seekingalpha.com • -
Novavax to Participate in Upcoming September Conferences
prnewswire.com • -
Novavax: Staying Long Despite Coming Up Short In Q2
seekingalpha.com • -
Novavax Plunges on Earnings Miss: Falling Knife or Buying Opp?
marketbeat.com • -
Novavax, Inc. (NVAX) Q2 2024 Earnings Call Transcript
seekingalpha.com •